Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Adenocarcinoma × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 100 Carcinoma, Non-Small-Cell Lung 26 Neoplasms 23 Neoplasm Metastasis 16 Carcinoma, Renal Cell 16 Prostatic Neoplasms 15 Uveal Melanoma 14 Lung Neoplasms 12 Pancreatic Neoplasms 11 Diabetes Mellitus, Insulin-Dependent, 12 11 Small Cell Lung Carcinoma 10 Colorectal Neoplasms 10 Carcinoma, Hepatocellular 9 Uterine Cervical Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Breast Neoplasms 8 Stomach Neoplasms 6 Sarcoma 6 Mesothelioma 6 Kidney Neoplasms 6 Head and Neck Neoplasms 6 Carcinoma, Transitional Cell 6 Recurrence 5 Ovarian Neoplasms 5 Lymphoma, Non-Hodgkin 5 Leukemia, Myeloid, Acute 5 Hodgkin Disease 5 Endometrial Neoplasms 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4

Interventions

Gemcitabine 5 130-nm albumin-bound paclitaxel 4 Fluorouracil 3 Albumin-Bound Paclitaxel 3 dehydroftorafur 2 Taxes 2 Oxaliplatin 2 tocilizumab 1 selicrelumab 1 niraparib 1 cobimetinib 1 atezolizumab 1 Tiragolumab 1 Resistance Training 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Pancreatectomy 1 PEGPH20 1 Nivolumab 1 Leucovorin 1 Irinotecan 1 Ipilimumab 1 Interleukin 1 Receptor Antagonist Protein 1 Electronic Health Records 1 Cisplatin 1 Bevacizumab 1 4-fluorobenzoyl-TN-14003 1 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03404960 2025-10-10

Parpvax

University of Pennsylvania

Phase 1/2 Completed

104 enrolled 11 charts

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡